Medtronic launches new AAA (abdominal aortic aneurysm) products:
This article was originally published in Clinica
Executive Summary
Medtronic has CE-marked for sale in Europe a new delivery system for implanting its Talent stent graft system for treating abdominal aortic aneurysms (AAAs). The Xcelerant delivery device features several enhancements that provide physicians with greater control during an implant and can serve to reduce implant procedure times, says the company. It incorporates an improved catheter material, and an integrated deployment handle to enhance trackability, improve kink resistance and decrease deployment forces. Regarding another of the firm's AAA devices, which is available in the US, Medtronic has announced the availability of a new graft material - called Resilient - for its AneuRx stent graft. Resilient is a higher density graft material designed to reduce porosity and improve durability.